Practical management of treatment-resistant depression

American Family Physician

Volumn 58, Issue 9, 1998, Pages 2059-2062

  Cadieux, Roger J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; CYTOCHROME P450; LEVOTHYROXINE SODIUM; LIOTHYRONINE SODIUM; LITHIUM; NEFAZODONE; PINDOLOL; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BRADYCARDIA; DEPRESSION; DIARRHEA; DOSE RESPONSE; ELECTROCONVULSIVE THERAPY; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; NAUSEA; SWEATING; VERTIGO;

ANTIDEPRESSIVE AGENTS; BUSPIRONE; DEPRESSION; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM; PINDOLOL; SEROTONIN AGENTS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TRIIODOTHYRONINE;

EID: 0032404183     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Joffe RT, Levitt AJ, Sokolov ST. Augmentation strategies. J Clin Psychiatry 1996:57(Suppl 7):25-31.
2. United States Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. Depression in primary care. Vol 2. Treatment of major depression. Rockville, Md.: Government Printing Office, 1993; AHCPR publication no. 93-0550.
3. Fava M, Rappe SM, Pava JA, Nierenberg AA, Alpert JE, Rosenbaum JF. Relapse in patients on long-term fluoxetine treatment. J Clin Psychiatry 1995; 56:52-5.
4. Phillips KA, Nierenberg AA. The assessment and treatment of refractory depression. J Clin Psychiatry 1994;55:20-6.
5. Thase ME, Rush JA. Treatment-resistant depression. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology. New York: Raven, 1995:1081-97.
6. Joffe RT, Levitt AJ. Antidepressant failure: augmentation or substitution? J Psychiatry Neurosci 1995;20:7-9.
7. Nemeroff CB. Augmentation strategies in patients with refractory depression. Depress Anxiety 1996-97;4:169-81.
8. Orrell M, Collins E, Shergill S, Katona C. Management of depression in the elderly by general practitioners: I. Use of antidepressants. Fam Pract 1995;12:5-11.
9. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
10. Nelson JC, Mazure CM, Bowers MB Jr, Jatlow PI. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 1991;48:303-7.
11. de Montigny C. Lithium addition in treatment-resistant depression. Int Clin Psychopharmacol 1994;9(Suppl 2):31-5.
12. Atack JR, Broughton HB, Pollack SJ. Inositol monophosphatase - a putative target for Li+ in the treatment of bipolar disorder. Trends Neurosci 1995;18:343-9.
13. Joffe RT, Singer W. A comparison of triiodothryonine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res 1990;32:241-5.
14. Bridges PK, Hodgkiss AD, Malizia AL. Practical management of treatment-resistant affective disorders. Br J Hosp Med 1995;54:501-6.
15. Artigas F. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation [Letter]. Arch Gen Psychiatry 1995;52:969-71.
16. Artigas F, Romero L, Perez V, Alvarez E. Augmentation of antidepressant efffects with 5HT-1A antagonists. Eur Neuropsychopharmacol 1996;6:16.
17. Jacobsen FM. Possible augmentation of antidepressant response by buspirone. J Clin Psychiatry 1991;52:217-20.
18. Bakish D. Fluoxetine potentiation by buspirone. Can J Psychiatry 1991;36:749-50.
19. Joffe RT, Schuller DR. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 1993;54:269-71.
20. Sussman N. Neurochemistry of serotonin and depression. Primary Psychiatry 1995;3:28-33.